The effect of azithromycin treatment on respiratory morbidity in children with down syndrome
Abstract Background Children with Down syndrome (DS) often experience recurrent and prolonged hospitalizations from respiratory infections. While Azithromycin has been increasingly used for lower-respiratory tract infections (LRTIs) in children, its potential benefits for DS patients are unexplored....
Saved in:
Main Authors: | Inbal Golan-Tripto, Omer Dor, Noga Arwas, Itai Hazan, Guy Hazan, Aviv Goldbart |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12887-025-05421-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: The effect of azithromycin treatment on respiratory morbidity in children with down syndrome
by: Inbal Golan-Tripto, et al.
Published: (2025-02-01) -
Incidence and predictors of respiratory tract infections among birth cohorts in Ethiopia, 2023
by: Fekade Demeke Bayou, et al.
Published: (2025-02-01) -
Respiratory pathogen spectrum and epidemiological trends in Hainan Province: a retrospective analysis from 2017 to 2023
by: Lvying Wu, et al.
Published: (2025-02-01) -
Did the resurgence of childhood lower respiratory infections offset the initial benefit of COVID-19-related non-pharmaceutical interventions in children? A time-series analysis
by: Inès Fafi, et al.
Published: (2025-02-01) -
Respiratory abnormalities in sarcoidosis: physiopathology and early diagnosis using oscillometry combined with respiratory modeling
by: Bruno Falcão Oliveira, et al.
Published: (2025-02-01)